XML 62 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1
Employee Benefits (Tables)
 12 Months Ended
Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Shares to be Issued and Remaining Shares Available for Future Issuance The following table provides detail of the number of shares to be issued upon exercise of outstanding stock-based awards and remaining shares available for future issuance under all of CTBI’s equity compensation plans as of December 31, 2024:

Plan Category (shares in thousands)
  
Number of
Shares to Be
Issued Upon
Exercise
    
Weighted
Average Price
    
Shares
Available for
Future Issuance
  
Equity compensation plans approved by shareholders:
                  
Stock options
    
0
    

0
      
336
(a)
Restricted stock
  
(c)
   
(b)
   
(a)
 
Performance units
  
(d)
   
(b)
   
(a)
 
Stock appreciation rights (“SARs”)
  
(e)
   
(b)
   
(a)
 
Total
                    
336
  

(a)
Under the 2025 Plan, which became effective February 1, 2025,550,000 shares are authorized for issuance; no shares have been issued as of December 31, 2024.  The maximum number of stock options that may be granted to a participant during any calendar year is 100,000 shares.  Under the 2015 Plan, 550,000 shares were authorized for issuance; 221,949 had been issued as of December 31, 2024.  In January of 2016, 18,069 restricted stock shares were issued under the terms of the 2015 Plan pursuant to awards granted under the 2006 Plan.  The 2015 Plan was rendered inactive on February 1, 2025.

(b)
Not applicable.

(c)
The maximum number of shares of restricted stock that may be granted is 550,000 shares, and the maximum that may be granted to a participant during any calendar year is 75,000 shares.

(d)
No performance units payable in stock had been issued as of December 31, 2024.  The maximum payment that can be made pursuant to performance units granted to any one participant in any calendar year is $1,000,000.

(e)
No SARS have been issued.  The maximum number of shares with respect to which SARs may be granted to a participant during any calendar year is 100,000 shares.
Unrecognized Compensation Cost, Grant-Date Fair Value of Shares Vested, Cash Received from Option Exercises and Actual Tax Benefit Realized for Tax Deductions from Option Exercises

The following table shows the unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the plans at December 31, 2024, 2023, and 2022 and the total grant-date fair value of shares vested, cash received from option exercises under all share-based payment arrangements, and the actual tax benefit realized for the tax deductions from option exercises of the share-based payment arrangements for the years ended December 31, 2024, 2023, and 2022.

(in thousands)
  
2024
    
2023
    
2022
  
Unrecognized compensation cost of nonvested share-based compensation arrangements granted under the plan at year-end
  
$
2,277
    
$
2,954
    
$
2,108
  
Total fair value of shares vested for the year
    
954
      
974
      
1,306
  
Cash received from option exercises under all share-based payment arrangements for the year
    
645
      
0
      
0
  
Tax benefit realized for the tax deductions from option exercises of the share-based payment arrangements for the year
    
84
      
0
      
0
  
2015 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Shares to be Issued and Remaining Shares Available for Future Issuance The following table details the shares available for future issuance under the 2015 Plan at December 31, 2024.

Plan Category
  
Shares Available for
Future Issuance
  
Shares available at January 1, 2024
    
348,146
  
Stock option grants
    
0
  
Restricted stock grants
    
(15,000
)
Forfeitures
    
2,437
  
Shares available for future issuance at December 31, 2024
    
335,583
  
Schedule of Restricted Stock Activity

The following table shows restricted stock activity for the 2015 Plan for the years ended December 31, 2024, 2023, and 2022:

December 31
  
2024
    
2023
    
2022
  
   
Grants
    
Weighted
Average
Fair
Value at
Grant
    
Grants
    
Weighted
Average
Fair
Value at
Grant
    
Grants
    
Weighted
Average
Fair
Value at
Grant
  
Outstanding at beginning of year
    
96,840
    
$
43.75
      
68,137
    
$
44.13
      
47,063
    
$
42.90
  
Granted
    
15,000
      
41.29
      
52,865
      
43.10
      
50,438
      
45.15
  
Vested
    
(22,831
)
    
43.37
      
(23,372
)
    
43.32
      
(29,364
)
    
43.92
  
Forfeited
    
(2,437
)
    
42.87
      
(790
)
    
44.87
      
0
      
-
  
Outstanding at end of year
    
86,572
    
$
43.45
      
96,840
    
$
43.75
      
68,137
    
$
44.13
  
2006 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

CTBI’s stock option activity for the 2006 Plan for the years ended December 31, 2024, 2023, and 2022 is summarized as follows:

December 31
  
2024
    
2023
    
2022
  
   
Options
    
Weighted
Average
Exercise
Price
    
Options
    
Weighted
Average
Exercise
Price
    
Options
    
Weighted
Average
Exercise
Price
  
Outstanding at beginning of year
    
20,000
    
$
32.27
      
20,000
    
$
32.27
      
20,000
    
$
32.27
  
Exercised
    
20,000
      
32.27
      
0
      
0
      
0
      
0
  
Outstanding at end of year
    
0
    
$
0.00
      
20,000
    
$
32.27
      
20,000
    
$
32.27
  
                                                 
Exercisable at end of year
    
0
    
$
0.00
      
20,000
    
$
32.27
      
20,000
    
$
32.27
  
Schedule of Intrinsic Values of Options Exercised, Exercisable, and Outstanding

The following table shows the intrinsic values of options exercised, exercisable, and outstanding for the 2006 Plan for the years ended December 31, 2024, 2023, and 2022:

(in thousands)
  
2024
    
2023
    
2022
  
Options exercised
  
$
335
    
$
0
    
$
0
  
Options exercisable
    
0
      
232
      
273
  
Outstanding options
    
0
      
232
      
273